{"id":4777,"date":"2022-04-07T18:55:00","date_gmt":"2022-04-07T09:55:00","guid":{"rendered":"https:\/\/www.imedisync.com\/?p=4777"},"modified":"2022-04-08T12:46:51","modified_gmt":"2022-04-08T03:46:51","slug":"imedisync-successfully-launches-the-future-of-tele-medicare-at-ces-2022","status":"publish","type":"post","link":"https:\/\/www.imedisync.com\/en\/imedisync-successfully-launches-the-future-of-tele-medicare-at-ces-2022\/","title":{"rendered":"iMediSync Successfully Launches the Future of Tele-Medicare at CES 2022"},"content":{"rendered":"<p><span style=\"color: #808080;\">Article Source: PRNewswire<\/span><\/p>\n<p><span style=\"color: #808080;\">Article Link: https:\/\/www.prnewswire.com\/news-releases\/imedisync-successfully-launches-the-future-of-tele-medicare-at-ces-2022-301467303.html<\/span><\/p>\n<p>&nbsp;<\/p>\n<p>iMediSync, A biotech startup company from\u00a0<span class=\"xn-location\">Seoul, South Korea<\/span>, successfully debuted at CES 2022 to introduce the new trend of digital healthcare under their motto\u00a0\u2013 Overcome Mental Pandemic in just 10 Min.<\/p>\n<p>&nbsp;<\/p>\n<p>At the event, the company presented iSyncWave, a\u00a0dry EEG helmet that provides EEG, HRV measurement equipped with the world firs<span id=\"spanHghlt5684\">t<\/span>\u00a0age\/gender matching Norm DB built with over 1,800 healthy brainwaves to provide a comparative analysis report to the subject.<\/p>\n<div id=\"attachment_4779\" style=\"width: 410px\" class=\"wp-caption aligncenter\"><img aria-describedby=\"caption-attachment-4779\" loading=\"lazy\" class=\"size-full wp-image-4779\" src=\"https:\/\/www.imedisync.com\/wp-content\/uploads\/2022\/04\/Attendee_experiencing_the_new_iSyncWave_at_the_iMediSync_booth.jpeg\" alt=\"\" width=\"400\" height=\"300\" \/><p id=\"caption-attachment-4779\" class=\"wp-caption-text\">Attendee experiencing the new iSyncWave at the iMediSync booth<\/p><\/div>\n<p>iSyncWave&#8217;s main features follow below:<\/p>\n<ul>\n<li>Nineteen channel electrodes with gear that automatically adjust to the 10\/20 system<\/li>\n<li>Age\/gender matching EEG and HRV analysis &amp; assessment report in 10 minutes<\/li>\n<li><span id=\"spanHghltabb6\">PBM &#8211; Near InfraRed LED Therapy<\/span><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p>During CES 2022, the company caught the attention of the media and visitors from all over the globe. Each day, more\u00a0than three hundred visitors came to the booth including audiences such as doctors, clinicians, entrepreneurs, YouTubers, influencers, and interested parties.<\/p>\n<p>&nbsp;<\/p>\n<p>On the first day of CES, nearly one hundred visitors\u00a0were able to participate\u00a0in their real-time brainwave measurement and to learn more about the brain and QEEG.<\/p>\n<p>&nbsp;<\/p>\n<p>A promising start for the iMediSync continued its momentum with interest from all kinds of audiences including the CTA VIP tours.<\/p>\n<p>&nbsp;<\/p>\n<p>The CEO Dr.\u00a0<span class=\"xn-person\">Seung Wan Kang<\/span>\u00a0comments\u00a0&#8220;The purpose of this showcase is to introduce our technology and our goal that we will provide life-changing mental healthcare experience in the field of neuro-mental illness biomarker with our patent EEG\/HRV technology, we strive to provide an optimized individual mental healthcare service in the post-Covid-19 era.&#8221;<\/p>\n<p>&nbsp;<\/p>\n<p>Aside from iMediSync&#8217;s\u00a0innovation and technology, the booth received numerous visits from key personne<span id=\"spanHghlt9aba\">l\u00a0to d<\/span>iscuss collaboration in digital healthcare\u00a0fields an<span id=\"spanHghlt11c0\">d\u00a0t<\/span>o expand to the global market of brain science and neurology.<\/p>\n<p>&nbsp;<\/p>\n<p>iMediSync, expecting the IPO this year\u00a0has established close cooperation with various research facilities and medical organization around the world is continuing discussion with major pharmaceutical companies for cooperation.<\/p>\n<p>&nbsp;<\/p>\n<p>With\u00a0the Korean FDA approval for their product and the software, iMediSync\u00a0expects the FDA and CE approval in the first half of 2022 to expand further on their biomarkers along with developing a next-level product to declare themselves as a trend leader in the field.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Article Source: PRNewswire Article Link: https:\/\/www.prnewswire.com\/news-releases\/imedisync-successfully-launches-the-future-of-tele-medicare-at-ces-2022-301467303.html &nbsp; iMediSync,&#8230;<\/p>\n","protected":false},"author":1,"featured_media":4781,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[26],"tags":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.imedisync.com\/en\/wp-json\/wp\/v2\/posts\/4777"}],"collection":[{"href":"https:\/\/www.imedisync.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.imedisync.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.imedisync.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.imedisync.com\/en\/wp-json\/wp\/v2\/comments?post=4777"}],"version-history":[{"count":5,"href":"https:\/\/www.imedisync.com\/en\/wp-json\/wp\/v2\/posts\/4777\/revisions"}],"predecessor-version":[{"id":4786,"href":"https:\/\/www.imedisync.com\/en\/wp-json\/wp\/v2\/posts\/4777\/revisions\/4786"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.imedisync.com\/en\/wp-json\/wp\/v2\/media\/4781"}],"wp:attachment":[{"href":"https:\/\/www.imedisync.com\/en\/wp-json\/wp\/v2\/media?parent=4777"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.imedisync.com\/en\/wp-json\/wp\/v2\/categories?post=4777"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.imedisync.com\/en\/wp-json\/wp\/v2\/tags?post=4777"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}